NCT03607045 is a NA clinical trial of headless screw in Boxer's Fracture, sponsored by Faculdade de Medicina do ABC.

Who is sponsoring NCT03607045?

NCT03607045 is sponsored by Faculdade de Medicina do ABC.

What drugs are being tested in NCT03607045?

Interventions in NCT03607045: headless screw.

What condition does NCT03607045 study?

NCT03607045 studies Boxer's Fracture.

Is NCT03607045 still recruiting?

NCT03607045 is currently status unknown. Last updated 30 July 2019.

Last reviewed 2019-07-30 · How we verify

NCT03607045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Headless Screws x Bouquet in Boxer's Fracture

Status unknown NA Last updated 30 July 2019

What this trial tests

NA trial testing headless screw in Boxer's Fracture in 24 participants. Status unknown.

Timeline

1 February 2019

Primary endpoint
5 June 2019

10 December 2020

Quick facts

Lead sponsor	Faculdade de Medicina do ABC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	24
Start date	1 February 2019
Primary completion	5 June 2019
Estimated completion	10 December 2020
Sites	1 location across Brazil

Drugs / interventions tested

headless screw

Conditions studied

Boxer's Fracture — all drugs for Boxer's Fracture →

Sponsor

Faculdade de Medicina do ABC — full company profile →

Who can join

Adults 18 to 60, any sex, with Boxer's Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite the high prevalence (20% of the hand fractures) of unstable neck metacarpals fractures (boxer's fractures) there is still no consensus concerning the preferred method and ideal moment of treatment, especially in active patients where the time or type of management can have a strong psychological impact on the outcomes. The use of intramedullar technique (headless intramedular screws or bouquet technique fixation) as definitive treatment of unstable boxer's fractures in active patients at the first week, may be a good choice of treatment. This technique is fast, safe, minimally invasive and easily performed reproducible method, without address the extensor tendon to prevent tendon adhesion and joint stiffness, unable earlier functional recovery and shorten the working return time of these patients. Choose a reproducible and effective method, which presents a cost / benefit compatible with our reality. The goal of the present study is to compare working return time, VAS (visual analogue score), quick DASH (disability arm, shoulder and hand) and radiographic outcomes of two methods of definitive internal fixation in active patients in boxer's fractures, operated in the first week.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Boxer's Fracture

Currently open trials in the same condition.

NCT06449755 — Elastic Nail Versus Screw for Intramedullary Fixation of Displaced Fractures of the Fifth Metacarpal Neck · NA · recruiting

Other Faculdade de Medicina do ABC trials

Trials by the same sponsor.

NCT05011240 — Parent-mediated Social-communication Therapy for Young Children Living in Poverty in Brazil · NA · unknown
NCT05072756 — Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits · completed
NCT05050981 — Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quali · completed
NCT06872385 — Profile of Brazilian Climacteric Women: the Brazilian Menopause Study · completed
NCT04181346 — Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03607045 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Faculdade de Medicina do ABC
Last refreshed: 30 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03607045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing